Luojia Yang

555 total citations · 1 hit paper
8 papers, 234 citations indexed

About

Luojia Yang is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Luojia Yang has authored 8 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Luojia Yang's work include SARS-CoV-2 and COVID-19 Research (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). Luojia Yang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). Luojia Yang collaborates with scholars based in United States, Japan and China. Luojia Yang's co-authors include Sidi Chen, Giacomo Sferruzza, Liqun Zhou, Stanley Z. Lam, Lupeng Ye, Lei Peng, Yueqi Zhang, Paul Clark, Paul Renauer and Madison S. Strine and has published in prestigious journals such as Nature Communications, Nature Biotechnology and Cell Reports.

In The Last Decade

Luojia Yang

8 papers receiving 232 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors

2024 145 citations Giacomo Sferruzza, Luojia Yang et al. Cellular and Molecular Immunology profile →

Peers

Luojia Yang

ONCOL

IMMUN

MB

ID

BE

Elizabeth Jinks United Kingdom

Donald Bastin Canada

Katarzyna Olesek Netherlands

Jordan Denizeau France

Isabel Vogler Germany

Jeanette M. Pots Netherlands

Joseph M. Leal United States

Gwennaëlle Monnot Switzerland

E. Lake Potter United States

Sebastian Jarosch Germany

Elizabeth Jinks United Kingdom

Luojia Yang

91 ×0.8

ONCOL

109 ×1.0

IMMUN

74 ×0.9

MB

29 ×0.9

ID

21 ×0.8

BE

Citations per year, relative to Luojia Yang Luojia Yang (= 1×) peers Elizabeth Jinks

Countries citing papers authored by Luojia Yang

Since Specialization

Citations

This map shows the geographic impact of Luojia Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luojia Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luojia Yang more than expected).

Fields of papers citing papers by Luojia Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luojia Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luojia Yang. The network helps show where Luojia Yang may publish in the future.

Co-authorship network of co-authors of Luojia Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Luojia Yang. A scholar is included among the top collaborators of Luojia Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luojia Yang. Luojia Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Fang, Zhenhao, Valter Silva Monteiro, L. Romero, et al.. (2025). A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity. Nature Biomedical Engineering. 10(3). 501–516. 1 indexed citations

2.

Sferruzza, Giacomo, et al.. (2024). CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cellular and Molecular Immunology. 21(10). 1089–1108. 145 indexed citations breakdown →

3.

Renauer, Paul, Giacomo Sferruzza, Luojia Yang, et al.. (2024). In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy. Nature Biotechnology. 43(5). 752–761. 26 indexed citations

4.

Zhou, Liqun, Luojia Yang, Yanzhi Feng, & Sidi Chen. (2023). Pooled screening with next-generation gene editing tools. Current Opinion in Biomedical Engineering. 28. 100479–100479. 1 indexed citations

5.

Ye, Lupeng, Stanley Z. Lam, Luojia Yang, et al.. (2023). AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells. Nature Biomedical Engineering. 8(2). 132–148. 20 indexed citations

6.

Ren, Ping, Lei Peng, Luojia Yang, et al.. (2023). RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq. Cell chemical biology. 30(1). 85–96.e6. 1 indexed citations

7.

Devarkar, Swapnil C., Ivan B. Lomakin, Luojia Yang, et al.. (2023). Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses. Cell Reports. 42(10). 113156–113156. 7 indexed citations

8.

Fang, Zhenhao, Lei Peng, Renata B. Filler, et al.. (2022). Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2. Nature Communications. 13(1). 3250–3250. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact